Results for tag: "ACAM2000"

The ACAM2000 market is a segment of the vaccine industry that focuses on the production of smallpox vaccines. The vaccine is used to protect against the Variola virus, which is the cause of smallpox. It is the only vaccine approved by the US Food and Drug Administration (FDA) for the prevention of smallpox. The ACAM2000 market is a niche market, as the vaccine is only used in certain circumstances, such as for military personnel and healthcare workers. The ACAM2000 market is highly regulated, with the FDA setting strict standards for the production and distribution of the vaccine. The market is also subject to government contracts, as the vaccine is often purchased by governments for use in their military and healthcare systems. Companies in the ACAM2000 market include Emergent BioSolutions, Bavarian Nordic, and Sanofi Pasteur. Show Less Read more